Authors:
Colnot, DR
Quak, JJ
Roos, JC
de Bree, R
Wilhelm, AJ
Snow, GB
van Dongen, GAMS
Citation: Dr. Colnot et al., Radioimmunotherapy in patients with head and neck squamous cell carcinoma:Initial experience, HEAD NECK, 23(7), 2001, pp. 559-565
Authors:
Van Coeverden, SCCM
De Ridder, CM
Roos, JC
Van't Hof, MA
Netelenbos, JC
Delemarre-Van de Waal, HA
Citation: Sccm. Van Coeverden et al., Pubertal maturation characteristics and the rate of bone mass development longitudinally toward menarche, J BONE MIN, 16(4), 2001, pp. 774-781
Authors:
Pluijm, SMF
Visser, M
Smit, JH
Popp-Snijders, C
Roos, JC
Lips, P
Citation: Smf. Pluijm et al., Determinants of bone mineral density in older men and women: Body composition as mediator, J BONE MIN, 16(11), 2001, pp. 2142-2151
Authors:
Colnot, DR
Wilhelm, AJ
Cloos, J
Roos, JC
de Bree, R
Quak, JJ
Snow, GB
van Dongen, GAMS
Citation: Dr. Colnot et al., Evaluation of limited blood sampling in a preceding Tc-99m-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of Re-186-cMAb U36 radioimmunotherapy, J NUCL MED, 42(9), 2001, pp. 1364-1367
Authors:
Van Zanten-Przybysz, I
Molthoff, CF
Roos, JC
Verheijen, RH
Van Hof, A
Buist, MR
Prinssen, HM
Den Hollander, W
Kenemans, P
Citation: I. Van Zanten-przybysz et al., Influence of the route of administration on targeting of ovarian cancer with the chimeric monoclonal antibody MOv18: I.v. vs. i.p., INT J CANC, 92(1), 2001, pp. 106-114
Authors:
Kemper, HCG
Twisk, JWR
van Mechelen, W
Post, GB
Roos, JC
Lips, P
Citation: Hcg. Kemper et al., A fifteen-year longitudinal study in young adults on the relation of physical activity and fitness with the development of the bone mass: The Amsterdam Growth and Health Longitudinal Study, BONE, 27(6), 2000, pp. 847-853
Authors:
Stroomer, JWG
Roos, JC
Sproll, M
Quak, JJ
Heider, KH
Wilhelm, BJ
Castelijns, JA
Meyer, R
Kwakkelstein, MO
Snow, GB
Adolf, GR
van Dongen, GAMS
Citation: Jwg. Stroomer et al., Safety and biodistribution of (99m)technetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients, CLIN CANC R, 6(8), 2000, pp. 3046-3055
Authors:
van Zanten-Przybysz, I
Molthoff, CF
Roos, JC
Plaizier, MA
Visser, GW
Pijpers, R
Kenemans, P
Verheijen, RH
Citation: I. Van Zanten-przybysz et al., Radioimmunotherapy with intravenously administered I-131-labeled chimeric monoclonal antibody MOv18 in patients with ovarian cancer, J NUCL MED, 41(7), 2000, pp. 1168-1176
Authors:
Colnot, DR
Quak, JJ
Roos, JC
van Lingen, A
Wilhelm, AJ
van Kamp, GJ
Huijgens, PC
Snow, GB
van Dongen, GAMS
Citation: Dr. Colnot et al., Phase I therapy study of Re-186-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck, J NUCL MED, 41(12), 2000, pp. 1999-2010
Authors:
Clement, EV
van der Wiel, H
Patka, P
Roos, JC
Lips, P
Citation: Ev. Clement et al., Long-term consequences of fracture of the lower leg: Cross-sectional studyand long-term longitudinal follow-up of bone mineral density in the hip after fracture of lower leg, BONE, 24(2), 1999, pp. 131-134
Authors:
Davies, Q
Perkins, AC
Roos, JC
Molthoff, CFM
Verheijen, RHM
Frier, M
Kenemans, P
Broadhead, T
Sopwith, M
Symonds, EM
Citation: Q. Davies et al., An immunoscintigraphic evaluation of the engineered human monoclonal antibody (hCTMO1) for use in the treatment of ovarian carcinoma, BR J OBST G, 106(1), 1999, pp. 31-37
Authors:
van Zanten-Przybysz, I
Molthoff, CFM
Visser, GWM
Verheijen, RMH
Plaizier, MABD
Pijpers, R
Kenemans, P
Roos, JC
Citation: I. Van Zanten-przybysz et al., I-131-labelled chimeric monoclonal antibody MOv18 in ovarian cancer patients: a pilot study, TUMOR TARG, 4(3), 1999, pp. 179-188
Citation: N. Koning et Jc. Roos, The continued influence of organic pollution on the water quality of the turbid Modder River, WATER SA, 25(3), 1999, pp. 285-292
Authors:
Hoorweg-Nijman, JJG
Kardos, G
Roos, JC
van Dijk, HJ
Netelenbos, C
Popp-Snijders, C
de Ridder, CM
Delemarre-van de Waal, HA
Citation: Jjg. Hoorweg-nijman et al., Bone mineral density and markers of bone turnover in young adult survivorsof childhood lymphoblastic leukaemia, CLIN ENDOCR, 50(2), 1999, pp. 237-244
Authors:
de Bree, R
Kuik, DJ
Quak, JJ
Roos, JC
van den Brekel, MWM
Castelijns, JA
van Wagtendonk, FW
Greuter, H
Snow, GB
van Dongen, GAMS
Citation: R. De Bree et al., The impact of tumour volume and other characteristics on uptake of radiolabelled monoclonal antibodies in tumour tissue of head and neck cancer patients, EUR J NUCL, 25(11), 1998, pp. 1562-1565